Skip to main content
Advertisement
Advertisement

RXST

RXST logo

RxSight, Inc. Common Stock

4.51
USD
Sponsored
-0.16
-3.43%
Oct 16, 15:58 UTC -4
Closed
exchange

After-Market

4.54

+0.03
+0.67%

RXST Earnings Reports

Positive Surprise Ratio

RXST beat 18 of 21 last estimates.

86%

Next Report

Date of Next Report
Nov 11, 2026
Estimate for Q3 26 (Revenue/ EPS)
$27.68M
/
-$0.27
Implied change from Q2 26 (Revenue/ EPS)
-17.96%
/
-3.57%
Implied change from Q3 25 (Revenue/ EPS)
-8.77%
/
+12.50%

RxSight, Inc. Common Stock earnings per share and revenue

On Aug 05, 2026, RXST reported earnings of -0.28 USD per share (EPS) for Q2 26, beating the estimate of -0.33 USD, resulting in a 13.82% surprise. Revenue reached 33.74 million, compared to an expected 33.20 million, with a 1.64% difference. The market reacted with a -3.34% price change (close before vs. close after earnings).
Looking ahead to Q3 26, -- analysts forecast an EPS of -0.27 USD, with revenue projected to reach 27.68 million USD, implying an decrease of -3.57% EPS, and decrease of -17.96% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
Oct 08, 2026 For Q1 27
Estimate
-$0.11
Actual
-$0.04
Surprise
+65.40%
FAQ
For Q2 2026, RxSight, Inc. Common Stock reported EPS of -$0.28, beating estimates by 13.82%, and revenue of $33.74M, 1.64% above expectations.
The stock price moved down -3.34%, changed from $6.29 before the earnings release to $6.08 the day after.
The next earning report is scheduled for Nov 11, 2026.
Based on -- analysts, RxSight, Inc. Common Stock is expected to report EPS of -$0.27 and revenue of $27.68M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement